The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
Recruiting · NCT05414409 · Registry updated 2026-08-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 1 diabetes mellitus | Recruiting | Phase 2 | 2026-08-21 | NCT05414409 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Heba M. Ismail | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 617 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Indiana University School of Medicine | Indianapolis | United States | 71 |